

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.50847738 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.50847738 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.24708097 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24708097 |
| 5 | central nervous system myelination (GO:0022010) | 6.85297887 |
| 6 | axon ensheathment in central nervous system (GO:0032291) | 6.85297887 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.51975273 |
| 8 | glutamate secretion (GO:0014047) | 6.23424009 |
| 9 | synaptic vesicle maturation (GO:0016188) | 6.17725950 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.09842151 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 6.03836159 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.85760495 |
| 13 | urea metabolic process (GO:0019627) | 5.78135284 |
| 14 | urea cycle (GO:0000050) | 5.78135284 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.76365560 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.62762665 |
| 17 | tryptophan catabolic process (GO:0006569) | 5.61608704 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 5.61608704 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 5.61608704 |
| 20 | kynurenine metabolic process (GO:0070189) | 5.54061855 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 5.42490391 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.39176343 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.38893787 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.38456084 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36136302 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.32096611 |
| 27 | tryptophan metabolic process (GO:0006568) | 5.29240232 |
| 28 | cysteine metabolic process (GO:0006534) | 5.20676973 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.20222376 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 5.15461276 |
| 31 | sodium ion export (GO:0071436) | 5.12691850 |
| 32 | L-amino acid import (GO:0043092) | 5.05667280 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.90561720 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.89650325 |
| 35 | protein carboxylation (GO:0018214) | 4.89650325 |
| 36 | aldehyde catabolic process (GO:0046185) | 4.88492342 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.85860339 |
| 38 | bile acid metabolic process (GO:0008206) | 4.84884460 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.83732687 |
| 40 | glycine metabolic process (GO:0006544) | 4.79750700 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.79312512 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.77580985 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.75850988 |
| 44 | coenzyme catabolic process (GO:0009109) | 4.73421399 |
| 45 | aromatic amino acid family metabolic process (GO:0009072) | 4.72361567 |
| 46 | regulation of protein activation cascade (GO:2000257) | 4.67744303 |
| 47 | serine family amino acid biosynthetic process (GO:0009070) | 4.66406217 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.64052321 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61529271 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.61529271 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.61529271 |
| 52 | regulation of synaptic vesicle transport (GO:1902803) | 4.61332836 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.60000460 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.54110373 |
| 55 | amino acid import (GO:0043090) | 4.52228863 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.51134432 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 4.50366388 |
| 58 | neurotransmitter secretion (GO:0007269) | 4.47073275 |
| 59 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46685285 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.45848852 |
| 61 | lysine catabolic process (GO:0006554) | 4.45748972 |
| 62 | lysine metabolic process (GO:0006553) | 4.45748972 |
| 63 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.45267046 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.40496965 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.40496965 |
| 66 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.36835341 |
| 67 | regulation of complement activation (GO:0030449) | 4.33417284 |
| 68 | positive regulation of synapse maturation (GO:0090129) | 4.32434257 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.28959474 |
| 70 | ethanol oxidation (GO:0006069) | 4.28913567 |
| 71 | negative regulation of sterol transport (GO:0032372) | 4.27976048 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 4.27976048 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.27664424 |
| 74 | arginine metabolic process (GO:0006525) | 4.26310251 |
| 75 | potassium ion homeostasis (GO:0055075) | 4.21628759 |
| 76 | cerebellar granule cell differentiation (GO:0021707) | 4.18180464 |
| 77 | phospholipid efflux (GO:0033700) | 4.14497977 |
| 78 | bile acid and bile salt transport (GO:0015721) | 4.13278621 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 4.12218127 |
| 80 | cofactor catabolic process (GO:0051187) | 4.09365012 |
| 81 | L-serine metabolic process (GO:0006563) | 4.02674889 |
| 82 | locomotory exploration behavior (GO:0035641) | 4.00913522 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.98591550 |
| 84 | amine catabolic process (GO:0009310) | 3.98591550 |
| 85 | glutamate metabolic process (GO:0006536) | 3.98103254 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96439886 |
| 87 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.94928129 |
| 88 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.94585973 |
| 89 | neuronal ion channel clustering (GO:0045161) | 3.92794994 |
| 90 | cellular glucuronidation (GO:0052695) | 3.91675163 |
| 91 | cholesterol efflux (GO:0033344) | 3.91395462 |
| 92 | ketone body metabolic process (GO:1902224) | 3.90205722 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.89096585 |
| 94 | indolalkylamine metabolic process (GO:0006586) | 3.87690583 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.86452306 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.85299980 |
| 97 | drug catabolic process (GO:0042737) | 3.83243287 |
| 98 | carboxylic acid catabolic process (GO:0046395) | 3.76395813 |
| 99 | organic acid catabolic process (GO:0016054) | 3.76395813 |
| 100 | potassium ion import (GO:0010107) | 3.72239524 |
| 101 | fibrinolysis (GO:0042730) | 3.70284179 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.70155516 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67523261 |
| 104 | drug metabolic process (GO:0017144) | 3.66966763 |
| 105 | plasma lipoprotein particle assembly (GO:0034377) | 3.65350406 |
| 106 | response to nitrosative stress (GO:0051409) | 3.64923347 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.64421563 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 3.62823951 |
| 109 | regulation of ARF protein signal transduction (GO:0032012) | 3.59993514 |
| 110 | neurotransmitter transport (GO:0006836) | 3.59937898 |
| 111 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.59131712 |
| 112 | complement activation (GO:0006956) | 3.58264577 |
| 113 | primary alcohol catabolic process (GO:0034310) | 3.58194346 |
| 114 | myelin maintenance (GO:0043217) | 3.57850061 |
| 115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.57659548 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57169435 |
| 117 | negative regulation of lipase activity (GO:0060192) | 3.56376905 |
| 118 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.56217124 |
| 119 | aspartate family amino acid catabolic process (GO:0009068) | 3.55645299 |
| 120 | cholesterol homeostasis (GO:0042632) | 3.54921689 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.54892037 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.54892037 |
| 123 | protein activation cascade (GO:0072376) | 3.52680413 |
| 124 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51624622 |
| 125 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51098663 |
| 126 | ethanol metabolic process (GO:0006067) | 3.49852386 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.48433498 |
| 128 | sterol homeostasis (GO:0055092) | 3.48328371 |
| 129 | flavonoid metabolic process (GO:0009812) | 3.48150289 |
| 130 | one-carbon metabolic process (GO:0006730) | 3.46888565 |
| 131 | monocarboxylic acid catabolic process (GO:0072329) | 3.46321210 |
| 132 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.42998118 |
| 133 | regulation of neurotransmitter levels (GO:0001505) | 3.42615888 |
| 134 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.41309689 |
| 135 | regulation of synaptic plasticity (GO:0048167) | 3.37906179 |
| 136 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.35771129 |
| 137 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.33750761 |
| 138 | neuromuscular process controlling balance (GO:0050885) | 3.30223211 |
| 139 | exploration behavior (GO:0035640) | 3.29086365 |
| 140 | acidic amino acid transport (GO:0015800) | 3.27440182 |
| 141 | vocalization behavior (GO:0071625) | 3.26713583 |
| 142 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26284906 |
| 143 | regulation of synapse maturation (GO:0090128) | 3.25688876 |
| 144 | positive regulation of membrane potential (GO:0045838) | 3.22591343 |
| 145 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.17750108 |
| 146 | neuromuscular process controlling posture (GO:0050884) | 3.17065985 |
| 147 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12784807 |
| 148 | synaptic transmission, glutamatergic (GO:0035249) | 3.06670896 |
| 149 | cell communication by electrical coupling (GO:0010644) | 3.05464089 |
| 150 | regulation of neurotransmitter secretion (GO:0046928) | 3.05213196 |
| 151 | cellular sodium ion homeostasis (GO:0006883) | 3.04672550 |
| 152 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.04602360 |
| 153 | neuronal action potential propagation (GO:0019227) | 3.04601871 |
| 154 | neurotransmitter uptake (GO:0001504) | 3.04436929 |
| 155 | positive regulation of dendritic spine development (GO:0060999) | 3.04202344 |
| 156 | regulation of synapse structural plasticity (GO:0051823) | 3.00857778 |
| 157 | gamma-aminobutyric acid transport (GO:0015812) | 2.94822317 |
| 158 | positive regulation of Rap GTPase activity (GO:0032854) | 2.92205031 |
| 159 | L-glutamate transport (GO:0015813) | 2.91913629 |
| 160 | long-term synaptic potentiation (GO:0060291) | 2.90577536 |
| 161 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.87079550 |
| 162 | substantia nigra development (GO:0021762) | 2.86262506 |
| 163 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.85791362 |
| 164 | long-term memory (GO:0007616) | 2.84901008 |
| 165 | synaptic vesicle endocytosis (GO:0048488) | 2.83066487 |
| 166 | negative regulation of inclusion body assembly (GO:0090084) | 2.82249940 |
| 167 | regulation of neurotransmitter transport (GO:0051588) | 2.79824250 |
| 168 | postsynaptic membrane organization (GO:0001941) | 2.77619102 |
| 169 | dicarboxylic acid transport (GO:0006835) | 2.70951747 |
| 170 | positive regulation of neurotransmitter transport (GO:0051590) | 2.70529523 |
| 171 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.69318694 |
| 172 | adenosine receptor signaling pathway (GO:0001973) | 2.68329939 |
| 173 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63469673 |
| 174 | regulation of synaptic transmission (GO:0050804) | 2.62262393 |
| 175 | regulation of female receptivity (GO:0045924) | 2.62239751 |
| 176 | neuron cell-cell adhesion (GO:0007158) | 2.61987350 |
| 177 | regulation of vesicle fusion (GO:0031338) | 2.61291965 |
| 178 | astrocyte development (GO:0014002) | 2.60988542 |
| 179 | regulation of inclusion body assembly (GO:0090083) | 2.60267070 |
| 180 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.59999786 |
| 181 | response to auditory stimulus (GO:0010996) | 2.58605604 |
| 182 | neuron-neuron synaptic transmission (GO:0007270) | 2.57793311 |
| 183 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56426536 |
| 184 | layer formation in cerebral cortex (GO:0021819) | 2.56057513 |
| 185 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.55191041 |
| 186 | regulation of Rap GTPase activity (GO:0032317) | 2.52943468 |
| 187 | establishment of mitochondrion localization (GO:0051654) | 2.52274088 |
| 188 | protein localization to synapse (GO:0035418) | 2.51248832 |
| 189 | cerebellar Purkinje cell layer development (GO:0021680) | 2.50871680 |
| 190 | female mating behavior (GO:0060180) | 2.48756396 |
| 191 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.48644257 |
| 192 | regulation of exocytosis (GO:0017157) | 2.47407975 |
| 193 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.46720128 |
| 194 | acid secretion (GO:0046717) | 2.44496091 |
| 195 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.39913436 |
| 196 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.39913436 |
| 197 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39609293 |
| 198 | adult walking behavior (GO:0007628) | 2.39469716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.75215002 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.71063990 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.59213402 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67837854 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.43144445 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.37500355 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.76321107 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.35478359 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.39773111 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.16139821 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.12291026 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.79544398 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64856975 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.63235185 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.46851684 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.39968531 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31763956 |
| 18 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.22380798 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.20994515 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19110676 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17282676 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04992293 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03477652 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5264179 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96007651 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95794848 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.95288508 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.93073648 |
| 29 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.91804725 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90630297 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.90075717 |
| 32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.89732876 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89726594 |
| 34 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.87637071 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.83097298 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.82709312 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82691959 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.82273342 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75537640 |
| 40 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.73458330 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.71880357 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71292549 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70263833 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.64718153 |
| 45 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.61377056 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.55807677 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52335189 |
| 48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52074564 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51229999 |
| 50 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.50597089 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48926423 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48291465 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48200882 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46873652 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45468176 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45391654 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45103064 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45050013 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44148534 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42221530 |
| 61 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.40974864 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40578352 |
| 63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40149246 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40149246 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38642781 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37990011 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37624186 |
| 68 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.36452080 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.33973635 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.33970126 |
| 71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32367328 |
| 72 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30403676 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30384189 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29792727 |
| 75 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29366452 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29043632 |
| 77 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.27829939 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27731677 |
| 79 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27600523 |
| 80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.26627206 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25873739 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25195413 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24840598 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24791513 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23783877 |
| 86 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.23328803 |
| 87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21001078 |
| 88 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20012036 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19583201 |
| 90 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.19517356 |
| 91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19209247 |
| 92 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18438909 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17654684 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16140479 |
| 95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15988126 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12474001 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12193355 |
| 98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11902802 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11852989 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10221844 |
| 101 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.08095143 |
| 102 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.08063808 |
| 103 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06938577 |
| 104 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05982725 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05919695 |
| 106 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05910213 |
| 107 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04764814 |
| 108 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04419481 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03059798 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02319196 |
| 111 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01984689 |
| 112 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01488258 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01311528 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00979496 |
| 115 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00632917 |
| 116 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00327370 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00206758 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00059624 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99359350 |
| 120 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.99036906 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98685417 |
| 122 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97573242 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97125984 |
| 124 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95917442 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95786650 |
| 126 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95273743 |
| 127 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94909009 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93994331 |
| 129 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93362601 |
| 130 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93167460 |
| 131 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89334581 |
| 132 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.83290232 |
| 133 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.81320468 |
| 134 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.80785829 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80396638 |
| 136 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80237346 |
| 137 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78860525 |
| 138 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.77418872 |
| 139 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.76257505 |
| 140 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75430159 |
| 141 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74902364 |
| 142 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74294988 |
| 143 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.73328870 |
| 144 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73235861 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.71821433 |
| 146 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.70630831 |
| 147 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.70095847 |
| 148 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67594870 |
| 149 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.67033786 |
| 150 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.66507620 |
| 151 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.64412721 |
| 152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.63505197 |
| 153 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63207367 |
| 154 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61914127 |
| 155 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.61508180 |
| 156 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60661045 |
| 157 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.60491323 |
| 158 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.58864467 |
| 159 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.58628398 |
| 160 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58532115 |
| 161 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.57462548 |
| 162 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55154075 |
| 163 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.54553010 |
| 164 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.54225755 |
| 165 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54159050 |
| 166 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.53941639 |
| 167 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.53781329 |
| 168 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53594024 |
| 169 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53144983 |
| 170 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.53016429 |
| 171 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.52479377 |
| 172 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51405560 |
| 173 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.50987046 |
| 174 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.48730273 |
| 175 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47607298 |
| 176 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.47387622 |
| 177 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.46512115 |
| 178 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.46137929 |
| 179 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.45923087 |
| 180 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.45749127 |
| 181 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45483486 |
| 182 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.45472382 |
| 183 | NCOR_22424771_ChIP-Seq_293T_Human | 0.45415921 |
| 184 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.45403406 |
| 185 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.45102638 |
| 186 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45090197 |
| 187 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.45004307 |
| 188 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.44407472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.18341721 |
| 2 | MP0005360_urolithiasis | 7.55204651 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.54970255 |
| 4 | MP0005365_abnormal_bile_salt | 6.06091058 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 5.62882412 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.34189161 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.90447334 |
| 8 | MP0004270_analgesia | 3.72887793 |
| 9 | MP0003252_abnormal_bile_duct | 3.59942749 |
| 10 | MP0003880_abnormal_central_pattern | 3.57435179 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.50364946 |
| 12 | MP0005423_abnormal_somatic_nervous | 3.43045291 |
| 13 | MP0002064_seizures | 3.39357481 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 3.38706270 |
| 15 | MP0009840_abnormal_foam_cell | 3.25345949 |
| 16 | MP0000920_abnormal_myelination | 2.95206219 |
| 17 | MP0005332_abnormal_amino_acid | 2.88728117 |
| 18 | MP0009745_abnormal_behavioral_response | 2.70446953 |
| 19 | MP0003879_abnormal_hair_cell | 2.69272211 |
| 20 | MP0005083_abnormal_biliary_tract | 2.60749814 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.58932120 |
| 22 | MP0002272_abnormal_nervous_system | 2.58165741 |
| 23 | MP0003195_calcinosis | 2.55944827 |
| 24 | MP0001486_abnormal_startle_reflex | 2.55883964 |
| 25 | MP0008569_lethality_at_weaning | 2.37092900 |
| 26 | MP0001666_abnormal_nutrient_absorption | 2.33655926 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.22700881 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.16279690 |
| 29 | MP0000609_abnormal_liver_physiology | 2.09557952 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 2.07245046 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 2.04491272 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 2.02563860 |
| 33 | MP0009697_abnormal_copulation | 1.96675255 |
| 34 | MP0005451_abnormal_body_composition | 1.94371386 |
| 35 | MP0009046_muscle_twitch | 1.94259269 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.93383213 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.86807110 |
| 38 | MP0001764_abnormal_homeostasis | 1.86329572 |
| 39 | MP0001970_abnormal_pain_threshold | 1.85029352 |
| 40 | MP0004885_abnormal_endolymph | 1.83628369 |
| 41 | MP0003868_abnormal_feces_composition | 1.83054077 |
| 42 | MP0003186_abnormal_redox_activity | 1.78376113 |
| 43 | MP0003633_abnormal_nervous_system | 1.77843291 |
| 44 | MP0001905_abnormal_dopamine_level | 1.74541587 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.73194090 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.73098408 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.70746077 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64554229 |
| 49 | MP0003011_delayed_dark_adaptation | 1.63381416 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.60059760 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.59400771 |
| 52 | MP0003631_nervous_system_phenotype | 1.53898468 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.50561091 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.50461320 |
| 55 | MP0003634_abnormal_glial_cell | 1.48735187 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.48276214 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.45998854 |
| 58 | MP0004742_abnormal_vestibular_system | 1.41587005 |
| 59 | MP0001440_abnormal_grooming_behavior | 1.38320849 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.38071551 |
| 61 | MP0004811_abnormal_neuron_physiology | 1.34736527 |
| 62 | MP0002736_abnormal_nociception_after | 1.33639452 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.33130842 |
| 64 | MP0002229_neurodegeneration | 1.32879385 |
| 65 | MP0003787_abnormal_imprinting | 1.32839081 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.31787043 |
| 67 | MP0002066_abnormal_motor_capabilities/c | 1.30176739 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.24746514 |
| 69 | MP0002254_reproductive_system_inflammat | 1.23872896 |
| 70 | MP0003632_abnormal_nervous_system | 1.23395843 |
| 71 | MP0003303_peritoneal_inflammation | 1.22110770 |
| 72 | MP0006082_CNS_inflammation | 1.21657163 |
| 73 | MP0000598_abnormal_liver_morphology | 1.20893432 |
| 74 | MP0008260_abnormal_autophagy | 1.18028156 |
| 75 | MP0009278_abnormal_bone_marrow | 1.13660218 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.13051544 |
| 77 | MP0005647_abnormal_sex_gland | 1.13001511 |
| 78 | MP0002822_catalepsy | 1.10847281 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 1.09657372 |
| 80 | MP0002882_abnormal_neuron_morphology | 1.09278542 |
| 81 | MP0005266_abnormal_metabolism | 1.08141444 |
| 82 | MP0004510_myositis | 1.07492365 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 1.06667864 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.05081958 |
| 85 | MP0001963_abnormal_hearing_physiology | 1.04474096 |
| 86 | MP0000955_abnormal_spinal_cord | 1.02711948 |
| 87 | MP0005646_abnormal_pituitary_gland | 1.02013402 |
| 88 | MP0009763_increased_sensitivity_to | 1.01156840 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.99390238 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.99360611 |
| 91 | MP0003718_maternal_effect | 0.98365098 |
| 92 | MP0001984_abnormal_olfaction | 0.95665866 |
| 93 | MP0000604_amyloidosis | 0.95584674 |
| 94 | MP0004924_abnormal_behavior | 0.88966704 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.88966704 |
| 96 | MP0009764_decreased_sensitivity_to | 0.88669038 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.88250406 |
| 98 | MP0003123_paternal_imprinting | 0.85864125 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.85139024 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.84378576 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.83671575 |
| 102 | MP0002876_abnormal_thyroid_physiology | 0.82548820 |
| 103 | MP0005408_hypopigmentation | 0.82467708 |
| 104 | MP0001348_abnormal_lacrimal_gland | 0.81942191 |
| 105 | MP0003705_abnormal_hypodermis_morpholog | 0.81744234 |
| 106 | MP0008469_abnormal_protein_level | 0.81607335 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.80753979 |
| 108 | MP0005000_abnormal_immune_tolerance | 0.77236746 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.76531380 |
| 110 | MP0005410_abnormal_fertilization | 0.76390306 |
| 111 | MP0005025_abnormal_response_to | 0.72554715 |
| 112 | MP0000778_abnormal_nervous_system | 0.71959168 |
| 113 | MP0004858_abnormal_nervous_system | 0.71214851 |
| 114 | MP0002152_abnormal_brain_morphology | 0.70282447 |
| 115 | MP0001177_atelectasis | 0.69605142 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.69206167 |
| 117 | MP0003866_abnormal_defecation | 0.69019192 |
| 118 | MP0008872_abnormal_physiological_respon | 0.68836496 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.66548805 |
| 120 | MP0003122_maternal_imprinting | 0.66185380 |
| 121 | MP0002971_abnormal_brown_adipose | 0.65990921 |
| 122 | MP0004142_abnormal_muscle_tone | 0.64112600 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.63861756 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.63625180 |
| 125 | MP0008873_increased_physiological_sensi | 0.63553787 |
| 126 | MP0009053_abnormal_anal_canal | 0.63360760 |
| 127 | MP0001790_abnormal_immune_system | 0.63071219 |
| 128 | MP0005387_immune_system_phenotype | 0.63071219 |
| 129 | MP0002069_abnormal_eating/drinking_beha | 0.62256381 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.62144132 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.61325990 |
| 132 | MP0005377_hearing/vestibular/ear_phenot | 0.60417646 |
| 133 | MP0003878_abnormal_ear_physiology | 0.60417646 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.59953899 |
| 135 | MP0001853_heart_inflammation | 0.59440592 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.55096848 |
| 137 | MP0005535_abnormal_body_temperature | 0.53713245 |
| 138 | MP0009672_abnormal_birth_weight | 0.51228369 |
| 139 | MP0004130_abnormal_muscle_cell | 0.50303271 |
| 140 | MP0009379_abnormal_foot_pigmentation | 0.50086241 |
| 141 | MP0005670_abnormal_white_adipose | 0.49494726 |
| 142 | MP0005395_other_phenotype | 0.46979719 |
| 143 | MP0003329_amyloid_beta_deposits | 0.46690885 |
| 144 | MP0003690_abnormal_glial_cell | 0.46409618 |
| 145 | MP0005334_abnormal_fat_pad | 0.46308382 |
| 146 | MP0005448_abnormal_energy_balance | 0.45037904 |
| 147 | MP0003646_muscle_fatigue | 0.44759028 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.44639703 |
| 149 | MP0008874_decreased_physiological_sensi | 0.43136025 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.42397809 |
| 151 | MP0001756_abnormal_urination | 0.39372665 |
| 152 | MP0001661_extended_life_span | 0.37311488 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.34336393 |
| 154 | MP0002132_abnormal_respiratory_system | 0.33260920 |
| 155 | MP0002269_muscular_atrophy | 0.33075962 |
| 156 | MP0002136_abnormal_kidney_physiology | 0.32025910 |
| 157 | MP0003953_abnormal_hormone_level | 0.31137140 |
| 158 | MP0005187_abnormal_penis_morphology | 0.27962764 |
| 159 | MP0005464_abnormal_platelet_physiology | 0.27636859 |
| 160 | MP0003436_decreased_susceptibility_to | 0.27221057 |
| 161 | MP0003699_abnormal_female_reproductive | 0.27201349 |
| 162 | MP0004883_abnormal_blood_vessel | 0.26916559 |
| 163 | MP0000579_abnormal_nail_morphology | 0.26544349 |
| 164 | MP0000230_abnormal_systemic_arterial | 0.26537179 |
| 165 | MP0002970_abnormal_white_adipose | 0.25290441 |
| 166 | MP0003075_altered_response_to | 0.24060681 |
| 167 | MP0005666_abnormal_adipose_tissue | 0.24057922 |
| 168 | MP0001243_abnormal_dermal_layer | 0.23665847 |
| 169 | MP0004147_increased_porphyrin_level | 0.23400144 |
| 170 | MP0001881_abnormal_mammary_gland | 0.22340111 |
| 171 | MP0000249_abnormal_blood_vessel | 0.22129161 |
| 172 | MP0005166_decreased_susceptibility_to | 0.21527874 |
| 173 | MP0002796_impaired_skin_barrier | 0.21260238 |
| 174 | MP0003221_abnormal_cardiomyocyte_apopto | 0.20917195 |
| 175 | MP0001529_abnormal_vocalization | 0.20169566 |
| 176 | MP0002332_abnormal_exercise_endurance | 0.18580443 |
| 177 | MP0002295_abnormal_pulmonary_circulatio | 0.18502896 |
| 178 | MP0000358_abnormal_cell_content/ | 0.18144256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.30091369 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.82313642 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.74230160 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.74006114 |
| 5 | Myokymia (HP:0002411) | 6.65419822 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.53757925 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.87076943 |
| 8 | Xanthomatosis (HP:0000991) | 5.68699558 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.33771945 |
| 10 | Ankle clonus (HP:0011448) | 5.06263885 |
| 11 | Focal motor seizures (HP:0011153) | 5.05190107 |
| 12 | Hyperammonemia (HP:0001987) | 4.85931918 |
| 13 | Diplopia (HP:0000651) | 4.85542373 |
| 14 | Abnormality of binocular vision (HP:0011514) | 4.85542373 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.82936525 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 4.65857987 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.58697192 |
| 18 | Complement deficiency (HP:0004431) | 4.55022346 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.45654917 |
| 20 | Neurofibrillary tangles (HP:0002185) | 4.43792885 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.43635636 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.38033089 |
| 23 | Epidermoid cyst (HP:0200040) | 4.27037475 |
| 24 | Visual hallucinations (HP:0002367) | 4.17153536 |
| 25 | Action tremor (HP:0002345) | 4.16470202 |
| 26 | Joint hemorrhage (HP:0005261) | 4.16314079 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.15577283 |
| 28 | Ketosis (HP:0001946) | 4.11486593 |
| 29 | Hyperglycinemia (HP:0002154) | 4.07079984 |
| 30 | Peripheral hypomyelination (HP:0007182) | 3.97730998 |
| 31 | Focal seizures (HP:0007359) | 3.96579669 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.84978633 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.84241475 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83584240 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.76635413 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76635413 |
| 37 | Hyperglycinuria (HP:0003108) | 3.73641469 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 3.72553843 |
| 39 | Epileptic encephalopathy (HP:0200134) | 3.72232865 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.65879182 |
| 41 | Fat malabsorption (HP:0002630) | 3.60742717 |
| 42 | Abnormal eating behavior (HP:0100738) | 3.57633107 |
| 43 | Hypoglycemic coma (HP:0001325) | 3.53150283 |
| 44 | Mutism (HP:0002300) | 3.49696304 |
| 45 | Intention tremor (HP:0002080) | 3.44986835 |
| 46 | Cerebral hypomyelination (HP:0006808) | 3.42389075 |
| 47 | Cerebral edema (HP:0002181) | 3.40680093 |
| 48 | Hypercholesterolemia (HP:0003124) | 3.40086375 |
| 49 | Delayed CNS myelination (HP:0002188) | 3.36334892 |
| 50 | Hyperbilirubinemia (HP:0002904) | 3.36144342 |
| 51 | Dysmetria (HP:0001310) | 3.33618401 |
| 52 | Neuronal loss in central nervous system (HP:0002529) | 3.32410234 |
| 53 | Abnormality of complement system (HP:0005339) | 3.28866043 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 3.26988624 |
| 55 | Abnormality of the intrinsic pathway (HP:0010989) | 3.25686538 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 3.20399926 |
| 57 | Spastic gait (HP:0002064) | 3.16010786 |
| 58 | Lethargy (HP:0001254) | 3.07871177 |
| 59 | Postural instability (HP:0002172) | 3.07463092 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 3.06283651 |
| 61 | Obstructive sleep apnea (HP:0002870) | 3.03415187 |
| 62 | Atonic seizures (HP:0010819) | 3.03293299 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03108127 |
| 64 | Febrile seizures (HP:0002373) | 3.00199507 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.98130818 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98130818 |
| 67 | Scanning speech (HP:0002168) | 2.94656985 |
| 68 | Delusions (HP:0000746) | 2.94471127 |
| 69 | Metabolic acidosis (HP:0001942) | 2.88387459 |
| 70 | Torticollis (HP:0000473) | 2.87178850 |
| 71 | Annular pancreas (HP:0001734) | 2.86455988 |
| 72 | Ketoacidosis (HP:0001993) | 2.86119742 |
| 73 | Papilledema (HP:0001085) | 2.84673625 |
| 74 | Hepatocellular carcinoma (HP:0001402) | 2.84667642 |
| 75 | Steatorrhea (HP:0002570) | 2.77176679 |
| 76 | Generalized tonic-clonic seizures (HP:0002069) | 2.77011031 |
| 77 | Increased serum pyruvate (HP:0003542) | 2.72820333 |
| 78 | Abnormality of glycolysis (HP:0004366) | 2.72820333 |
| 79 | Cholecystitis (HP:0001082) | 2.71741252 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.71741252 |
| 81 | Rigidity (HP:0002063) | 2.70523028 |
| 82 | Tetraplegia (HP:0002445) | 2.67494579 |
| 83 | Abnormality of the periventricular white matter (HP:0002518) | 2.67451797 |
| 84 | Absence seizures (HP:0002121) | 2.66823519 |
| 85 | Hemiplegia (HP:0002301) | 2.66522366 |
| 86 | Brushfield spots (HP:0001088) | 2.66128189 |
| 87 | Focal dystonia (HP:0004373) | 2.65893047 |
| 88 | Spontaneous abortion (HP:0005268) | 2.61743891 |
| 89 | Depression (HP:0000716) | 2.60988359 |
| 90 | Craniofacial dystonia (HP:0012179) | 2.54807124 |
| 91 | Progressive cerebellar ataxia (HP:0002073) | 2.54022728 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.53581807 |
| 93 | Cholelithiasis (HP:0001081) | 2.53072563 |
| 94 | Spastic diplegia (HP:0001264) | 2.51438128 |
| 95 | Rapidly progressive (HP:0003678) | 2.48565780 |
| 96 | Polyphagia (HP:0002591) | 2.48440008 |
| 97 | Hepatic necrosis (HP:0002605) | 2.48039114 |
| 98 | Increased circulating renin level (HP:0000848) | 2.47699088 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.45773613 |
| 100 | Opisthotonus (HP:0002179) | 2.43137478 |
| 101 | Malnutrition (HP:0004395) | 2.43116108 |
| 102 | Truncal ataxia (HP:0002078) | 2.41027412 |
| 103 | Skin nodule (HP:0200036) | 2.40934492 |
| 104 | Acute encephalopathy (HP:0006846) | 2.40488356 |
| 105 | Dialeptic seizures (HP:0011146) | 2.38803661 |
| 106 | Vomiting (HP:0002013) | 2.38299031 |
| 107 | Bradykinesia (HP:0002067) | 2.38227602 |
| 108 | Apathy (HP:0000741) | 2.37794297 |
| 109 | Clonus (HP:0002169) | 2.37683899 |
| 110 | Spastic tetraparesis (HP:0001285) | 2.37362177 |
| 111 | Diminished motivation (HP:0000745) | 2.35989024 |
| 112 | Myocardial infarction (HP:0001658) | 2.34506160 |
| 113 | Axonal loss (HP:0003447) | 2.33467557 |
| 114 | Neonatal onset (HP:0003623) | 2.33196511 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 2.32844373 |
| 116 | Irritability (HP:0000737) | 2.32007594 |
| 117 | Dementia (HP:0000726) | 2.31577663 |
| 118 | Increased cerebral lipofuscin (HP:0011813) | 2.27345637 |
| 119 | Systemic lupus erythematosus (HP:0002725) | 2.26448818 |
| 120 | Akinesia (HP:0002304) | 2.24257737 |
| 121 | Choreoathetosis (HP:0001266) | 2.24156084 |
| 122 | Slow saccadic eye movements (HP:0000514) | 2.23679189 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23390768 |
| 124 | Stridor (HP:0010307) | 2.21521418 |
| 125 | Nausea (HP:0002018) | 2.21378853 |
| 126 | Status epilepticus (HP:0002133) | 2.20280835 |
| 127 | Acanthocytosis (HP:0001927) | 2.18995218 |
| 128 | Memory impairment (HP:0002354) | 2.18876264 |
| 129 | Cellulitis (HP:0100658) | 2.17288036 |
| 130 | Agammaglobulinemia (HP:0004432) | 2.17030522 |
| 131 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16230331 |
| 132 | Vascular calcification (HP:0004934) | 2.14904724 |
| 133 | Insomnia (HP:0100785) | 2.11912994 |
| 134 | Urinary incontinence (HP:0000020) | 2.11208581 |
| 135 | Generalized aminoaciduria (HP:0002909) | 2.11080581 |
| 136 | Athetosis (HP:0002305) | 2.10749746 |
| 137 | Urinary urgency (HP:0000012) | 2.10244540 |
| 138 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08617746 |
| 139 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08617746 |
| 140 | Anxiety (HP:0000739) | 2.08557359 |
| 141 | Abnormality of the gallbladder (HP:0005264) | 2.07938214 |
| 142 | Abnormality of the corticospinal tract (HP:0002492) | 2.07254203 |
| 143 | Lower limb muscle weakness (HP:0007340) | 2.05726460 |
| 144 | Split foot (HP:0001839) | 2.04581618 |
| 145 | Spastic paraparesis (HP:0002313) | 2.03856397 |
| 146 | Gout (HP:0001997) | 1.99686798 |
| 147 | Hepatocellular necrosis (HP:0001404) | 1.99385965 |
| 148 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.98923338 |
| 149 | Late onset (HP:0003584) | 1.97181896 |
| 150 | Sleep apnea (HP:0010535) | 1.95023727 |
| 151 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.94912042 |
| 152 | Dysdiadochokinesis (HP:0002075) | 1.94688266 |
| 153 | Ventricular fibrillation (HP:0001663) | 1.93759340 |
| 154 | Limb dystonia (HP:0002451) | 1.93201540 |
| 155 | Pancreatitis (HP:0001733) | 1.92147603 |
| 156 | Thrombophlebitis (HP:0004418) | 1.92037641 |
| 157 | Enlarged kidneys (HP:0000105) | 1.91777889 |
| 158 | Amyloidosis (HP:0011034) | 1.91630797 |
| 159 | Sensorimotor neuropathy (HP:0007141) | 1.91448063 |
| 160 | Abnormality of iron homeostasis (HP:0011031) | 1.90113366 |
| 161 | Glomerulonephritis (HP:0000099) | 1.86293073 |
| 162 | Mitral stenosis (HP:0001718) | 1.85354337 |
| 163 | Abnormality of saccadic eye movements (HP:0000570) | 1.85030516 |
| 164 | Abnormal cartilage morphology (HP:0002763) | 1.84165992 |
| 165 | Elevated hepatic transaminases (HP:0002910) | 1.82978952 |
| 166 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.82615084 |
| 167 | Poikilocytosis (HP:0004447) | 1.82508086 |
| 168 | CNS demyelination (HP:0007305) | 1.81497383 |
| 169 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80187454 |
| 170 | Hyperparathyroidism (HP:0000843) | 1.79844414 |
| 171 | Spinal canal stenosis (HP:0003416) | 1.79798058 |
| 172 | Lactic acidosis (HP:0003128) | 1.79480352 |
| 173 | Cardiovascular calcification (HP:0011915) | 1.78969757 |
| 174 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77917567 |
| 175 | Epiphyseal stippling (HP:0010655) | 1.77901623 |
| 176 | Gingival bleeding (HP:0000225) | 1.76838350 |
| 177 | Polygenic inheritance (HP:0010982) | 1.76190198 |
| 178 | Hypophosphatemic rickets (HP:0004912) | 1.74923853 |
| 179 | Psychosis (HP:0000709) | 1.74151953 |
| 180 | Stereotypic behavior (HP:0000733) | 1.73896232 |
| 181 | Distal upper limb amyotrophy (HP:0007149) | 1.73468763 |
| 182 | Upper limb amyotrophy (HP:0009129) | 1.73468763 |
| 183 | Proximal tubulopathy (HP:0000114) | 1.73450176 |
| 184 | Hemiparesis (HP:0001269) | 1.72977871 |
| 185 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72881480 |
| 186 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72881480 |
| 187 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72881480 |
| 188 | Epileptiform EEG discharges (HP:0011182) | 1.72655447 |
| 189 | Abnormality of vitamin metabolism (HP:0100508) | 1.72448631 |
| 190 | Increased muscle lipid content (HP:0009058) | 1.72231146 |
| 191 | Foot dorsiflexor weakness (HP:0009027) | 1.71930302 |
| 192 | Dysostosis multiplex (HP:0000943) | 1.71510308 |
| 193 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.70664562 |
| 194 | Delayed myelination (HP:0012448) | 1.70521788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.53979892 |
| 2 | ERN1 | 3.51550304 |
| 3 | PAK6 | 3.23776638 |
| 4 | UHMK1 | 3.22761479 |
| 5 | ERBB4 | 3.22093424 |
| 6 | FGFR4 | 2.98926030 |
| 7 | SIK1 | 2.83210756 |
| 8 | NTRK3 | 2.77476468 |
| 9 | RIPK4 | 2.75786087 |
| 10 | PRPF4B | 2.59501543 |
| 11 | ABL2 | 2.57809452 |
| 12 | PRKD3 | 2.55812136 |
| 13 | PBK | 2.35095443 |
| 14 | EIF2AK1 | 2.34959880 |
| 15 | ARAF | 2.25111658 |
| 16 | PKN2 | 2.22694236 |
| 17 | CAMKK1 | 2.14952759 |
| 18 | MAP2K4 | 2.13070578 |
| 19 | NTRK2 | 2.03094697 |
| 20 | FLT3 | 1.99163335 |
| 21 | RIPK1 | 1.95550093 |
| 22 | GRK6 | 1.93929673 |
| 23 | KDR | 1.89924086 |
| 24 | BUB1 | 1.89223098 |
| 25 | TAOK3 | 1.85040647 |
| 26 | MARK1 | 1.69501956 |
| 27 | TESK1 | 1.69082988 |
| 28 | MAPK11 | 1.68950102 |
| 29 | MAP3K9 | 1.67823890 |
| 30 | TNK2 | 1.66179190 |
| 31 | CDK19 | 1.57320402 |
| 32 | MAP3K13 | 1.57162312 |
| 33 | KSR2 | 1.55814039 |
| 34 | PIK3CG | 1.54543269 |
| 35 | TESK2 | 1.52660083 |
| 36 | MINK1 | 1.52154881 |
| 37 | TYK2 | 1.50590991 |
| 38 | SIK2 | 1.48201031 |
| 39 | MARK2 | 1.47135883 |
| 40 | MYLK | 1.45173248 |
| 41 | GRK5 | 1.36470937 |
| 42 | DAPK2 | 1.35222851 |
| 43 | CAMK2B | 1.35114346 |
| 44 | FES | 1.34541303 |
| 45 | MAPK4 | 1.34337247 |
| 46 | STK16 | 1.33276134 |
| 47 | CDC7 | 1.30330260 |
| 48 | CDK5 | 1.27121282 |
| 49 | DYRK2 | 1.21779210 |
| 50 | SGK494 | 1.20008868 |
| 51 | SGK223 | 1.20008868 |
| 52 | MAP4K1 | 1.16453369 |
| 53 | MAP3K6 | 1.15688931 |
| 54 | CAMK1 | 1.15666769 |
| 55 | MST1R | 1.15263172 |
| 56 | DAPK1 | 1.14885379 |
| 57 | TYRO3 | 1.13672574 |
| 58 | PDPK1 | 1.07448167 |
| 59 | MAP3K10 | 1.06553032 |
| 60 | PINK1 | 1.05821263 |
| 61 | TAOK2 | 1.05815895 |
| 62 | NTRK1 | 1.05305431 |
| 63 | MAP3K1 | 1.03001615 |
| 64 | PDK1 | 1.02574457 |
| 65 | INSRR | 1.01501921 |
| 66 | TTK | 1.00616164 |
| 67 | MAPK12 | 0.99839377 |
| 68 | TGFBR1 | 0.94226565 |
| 69 | LATS2 | 0.89900528 |
| 70 | TAOK1 | 0.87938401 |
| 71 | CAMK2G | 0.87779469 |
| 72 | STK38 | 0.87480273 |
| 73 | NME2 | 0.86002560 |
| 74 | PKN1 | 0.85525881 |
| 75 | TRIB3 | 0.83666516 |
| 76 | NEK6 | 0.82630953 |
| 77 | ACVR1B | 0.82036197 |
| 78 | PRKCH | 0.81339367 |
| 79 | MAP2K3 | 0.79147164 |
| 80 | CAMK2D | 0.77619127 |
| 81 | CDK15 | 0.77570450 |
| 82 | MAP3K11 | 0.77442225 |
| 83 | PRKCZ | 0.77056491 |
| 84 | CDK11A | 0.76769049 |
| 85 | CDK14 | 0.75070936 |
| 86 | CAMK2A | 0.73316395 |
| 87 | EPHA4 | 0.73110711 |
| 88 | CSNK1G3 | 0.72755899 |
| 89 | TIE1 | 0.72601255 |
| 90 | FYN | 0.71711594 |
| 91 | STK11 | 0.71684631 |
| 92 | CDK18 | 0.70355934 |
| 93 | ALK | 0.70255917 |
| 94 | CSNK1G1 | 0.69056704 |
| 95 | JAK2 | 0.68755271 |
| 96 | PHKG2 | 0.68729527 |
| 97 | PHKG1 | 0.68729527 |
| 98 | MAP2K6 | 0.65290828 |
| 99 | SGK3 | 0.65288278 |
| 100 | ROCK2 | 0.65043487 |
| 101 | MAPK10 | 0.64862665 |
| 102 | PRKD1 | 0.64420615 |
| 103 | PLK1 | 0.62595171 |
| 104 | CDK4 | 0.62212077 |
| 105 | MUSK | 0.61223998 |
| 106 | MAPK13 | 0.61219003 |
| 107 | PDK4 | 0.60930216 |
| 108 | PDK3 | 0.60930216 |
| 109 | PRKACG | 0.60399677 |
| 110 | PLK4 | 0.60076409 |
| 111 | AURKA | 0.59795688 |
| 112 | PRKAA2 | 0.59598321 |
| 113 | CSNK2A2 | 0.57477738 |
| 114 | MAP3K3 | 0.57414179 |
| 115 | PRKG2 | 0.57250135 |
| 116 | PLK2 | 0.56864511 |
| 117 | SYK | 0.56693808 |
| 118 | SGK1 | 0.56232629 |
| 119 | CSNK2A1 | 0.55992038 |
| 120 | LIMK1 | 0.55835307 |
| 121 | TBK1 | 0.55723284 |
| 122 | SGK2 | 0.55391937 |
| 123 | EIF2AK3 | 0.55163239 |
| 124 | NEK9 | 0.54961771 |
| 125 | MAPK7 | 0.54805618 |
| 126 | PTK6 | 0.53845046 |
| 127 | WEE1 | 0.53664362 |
| 128 | AKT2 | 0.53469480 |
| 129 | TSSK6 | 0.53257075 |
| 130 | DYRK1A | 0.52969072 |
| 131 | MAP2K7 | 0.52611384 |
| 132 | IRAK2 | 0.52471356 |
| 133 | BMPR2 | 0.50360228 |
| 134 | PAK3 | 0.50320375 |
| 135 | CDK7 | 0.50117899 |
| 136 | RPS6KA2 | 0.49433584 |
| 137 | SMG1 | 0.46662263 |
| 138 | PRKD2 | 0.46497075 |
| 139 | NEK1 | 0.46130908 |
| 140 | GSK3A | 0.45383517 |
| 141 | BMX | 0.45211173 |
| 142 | STK38L | 0.44884805 |
| 143 | PRKCG | 0.43705388 |
| 144 | RAF1 | 0.43690998 |
| 145 | MAPKAPK3 | 0.43640803 |
| 146 | DYRK1B | 0.43071179 |
| 147 | PIM2 | 0.43010364 |
| 148 | ERBB2 | 0.42714879 |
| 149 | CAMK4 | 0.42313894 |
| 150 | FGFR2 | 0.41857917 |
| 151 | CDK6 | 0.40999922 |
| 152 | PAK1 | 0.40657657 |
| 153 | RPS6KA3 | 0.40313140 |
| 154 | BRSK1 | 0.39330779 |
| 155 | BLK | 0.38674206 |
| 156 | LMTK2 | 0.38501197 |
| 157 | PRKCQ | 0.38476430 |
| 158 | CSNK1G2 | 0.36809624 |
| 159 | PRKCA | 0.36068050 |
| 160 | DAPK3 | 0.35900616 |
| 161 | BMPR1B | 0.35048650 |
| 162 | STK4 | 0.34941348 |
| 163 | MAP2K2 | 0.34058061 |
| 164 | CDK8 | 0.33479553 |
| 165 | CSNK1E | 0.33457869 |
| 166 | BRAF | 0.33427155 |
| 167 | AURKB | 0.32777139 |
| 168 | SCYL2 | 0.32440670 |
| 169 | CSF1R | 0.31473497 |
| 170 | NME1 | 0.30580819 |
| 171 | DYRK3 | 0.30337513 |
| 172 | PAK4 | 0.29321926 |
| 173 | EIF2AK2 | 0.28524105 |
| 174 | MET | 0.27734462 |
| 175 | EPHB1 | 0.25509290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17515243 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.78445917 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.48781277 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08326765 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01313469 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90681776 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.76125320 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69118317 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.66818068 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64186061 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61982267 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46180386 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41985363 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.38422426 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37176704 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.34522283 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18484806 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16884721 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.14786116 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.12606471 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 2.07509089 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05584122 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05292984 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 2.04892421 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02825924 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.01154132 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 2.00504222 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96005175 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94230870 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.92286865 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.90048409 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88867492 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87804154 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87666352 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87620817 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85778437 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.82676554 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.81722629 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79842319 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77950065 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77317891 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71453035 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70000388 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69181460 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66295972 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64733295 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63921871 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62903719 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.62652912 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.60220645 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60198909 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58003650 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54009614 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49696321 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47312293 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46262466 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42517447 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40678154 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 1.40345851 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38705005 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36273061 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35255012 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.32195288 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30893525 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29345904 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 1.21453643 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17820647 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15057461 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13141966 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12383407 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 1.10109566 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08308222 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07544117 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06286587 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04314248 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03652112 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01691649 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01016684 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99365273 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98361513 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98204751 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.95665984 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95291228 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94934813 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94789147 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93240598 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93197741 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89353806 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88538235 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87276939 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86586995 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.86282671 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84050346 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82051178 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80718626 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79636764 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78987377 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78316978 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.75259943 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73557075 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72504974 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72369387 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68935906 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68556821 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.67547245 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66348652 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66209546 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65142848 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65048408 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64006173 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62108497 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.61719061 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.59328822 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58418040 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57273650 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57040129 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.55122264 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54149540 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54013140 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.53968935 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53292069 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.52962144 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52909596 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51777023 |
| 125 | Gap junction_Homo sapiens_hsa04540 | 0.51497540 |
| 126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50708268 |
| 127 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50611120 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49463843 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47879746 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47069302 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46963863 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46289641 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44070054 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43608173 |
| 135 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42990957 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42333516 |
| 137 | Proteasome_Homo sapiens_hsa03050 | 0.41730293 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.41680858 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40700488 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39592610 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37886357 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36297977 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36200851 |
| 144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36181677 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35555182 |
| 146 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35068683 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34537872 |
| 148 | Allograft rejection_Homo sapiens_hsa05330 | 0.34351116 |
| 149 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33682069 |
| 150 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32353341 |
| 151 | Phagosome_Homo sapiens_hsa04145 | 0.32244135 |
| 152 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31917391 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30981313 |
| 154 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29364936 |
| 155 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19596402 |
| 156 | Prion diseases_Homo sapiens_hsa05020 | 0.15826054 |
| 157 | Alzheimers disease_Homo sapiens_hsa05010 | 0.15491825 |
| 158 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.11164514 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10921606 |
| 160 | Huntingtons disease_Homo sapiens_hsa05016 | 0.08307293 |
| 161 | DNA replication_Homo sapiens_hsa03030 | 0.04629669 |
| 162 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03408036 |
| 163 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02932974 |
| 164 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01216288 |
| 165 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1775904 |
| 166 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1263014 |
| 167 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1129816 |
| 168 | Mismatch repair_Homo sapiens_hsa03430 | -0.1003759 |
| 169 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0797178 |
| 170 | Ribosome_Homo sapiens_hsa03010 | -0.0716510 |
| 171 | Base excision repair_Homo sapiens_hsa03410 | -0.0706452 |
| 172 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0659941 |
| 173 | RNA polymerase_Homo sapiens_hsa03020 | -0.0595055 |
| 174 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0434911 |
| 175 | Purine metabolism_Homo sapiens_hsa00230 | -0.0347311 |
| 176 | Insulin resistance_Homo sapiens_hsa04931 | -0.0199210 |
| 177 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0193495 |

